Sirtuins (SIRTs) As a Novel Target in Gastric Cancer

Int J Mol Sci. 2022 Dec 1;23(23):15119. doi: 10.3390/ijms232315119.

Abstract

Gastric cancer is a major health burden worldwide. Among all neoplasms, gastric cancer is the fifth most common and the third most deadly type of cancer. It is known that sirtuins (SIRTs), are NAD+-dependent histone deacetylases regulating important metabolic pathways. High expression of SIRTs in the human body can regulate metabolic processes; they prevent inflammation but also resist cell death and aging processes. The seven members of this family enzymes can also play a fundamental role in process of carcinogenesis by influencing cell viability, apoptosis and metastasis. This review collects and discusses the role of all seven sirtuins (SIRT1-SIRT7) in the pathogenesis of gastric cancer (GC).

Keywords: SIRT family; gastric adenocarcinoma; gastric cancer; pathogenesis; sirtuins; stomach cancer.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Cell Death
  • Cell Survival
  • Humans
  • Sirtuins* / metabolism
  • Stomach Neoplasms*

Substances

  • Sirtuins

Grants and funding

This research received no external funding.